Psychiatry & Neurology Doctors in Granger, IN Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Dr. Amer M. Kazi, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 6915 N Fir Rd, Granger, IN 46530 Phone: 574-234-2191    Fax: 574-231-7720

Dr. Mallikarjun Patta, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 11106 Birch Lake Dr, Granger, IN 46530 Phone: 574-247-0110

Dr. Jose Luis Lopez Jr., M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St Ste 100, Granger, IN 46530 Phone: 574-647-8542    Fax: 574-647-8549

Nadia Bowling, M.D Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St Ste 100, Granger, IN 46530 Phone: 574-647-8542    Fax: 574-647-8549

News Archive

VINARES project aims to strengthen evidence-based control of antibiotic use in Vietnam

The increasingly widespread resistance to antibiotics is a global threat. One of the most vulnerable countries is Vietnam, with 90 million inhabitants. In an attempt to change this development, the VINARES project was started in the autumn of 2012 led by researchers from Sweden, UK and Vietnam.

Mobile emergency alert system launched by Clearwave

The proliferation of GPS-enabled phones in recent years has allowed us to take yet another critical step toward push-button emergency location. But until recently, those tools have fallen short of the data emergency medical personnel need to successfully treat patients on-site, to notify next-of-kin and other important contacts, and to make informed decisions for patient transport.

ATS applauds NYC council for taking major step to protect public from risks linked with e-cigarettes

The American Thoracic Society, which has been based in New York City since 1905, is pleased with the city council vote yesterday prohibiting the use of electronic cigarettes in indoor public areas where smoking regular cigarettes is also banned.

Ampio announces advancement of NCE001 to preclinical development

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction and conducting clinical trials on its four lead drugs announced today the advancement of NCE001, from its proprietary methylphenidate derivatives family of compounds, to preclinical development for the treatment of glioblastoma multiforme, renal cell carcinoma and inflammatory breast cancer following the granting of multiple composition of matter and use patents in the USA, Canada, Europe and China.

Read more Medical News

› Verified 3 days ago